Findlay Park Partners’s Elevance Health ELV Stock Holding History

Findlay Park Partners’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-369,351	Closed	-$136M	–	59
2024 Q4	$136M	Buy	369,351 +6,500	+2%	+$2.72M	1.35%	38
2024 Q3	$189M	Buy	362,851 +70,700	+24%	+$37.8M	1.78%	26
2024 Q2	$158M	Sell	292,151 -2,200	-0.7%	-$1.16M	1.49%	31
2024 Q1	$153M	Sell	294,351 -5,000	-2%	-$2.49M	1.4%	30
2023 Q4	$141M	Buy	299,351 +78,841	+36%	+$36.5M	1.39%	33
2023 Q3	$96M	Buy	220,510 +55,636	+34%	+$25.2M	1.03%	45
2023 Q2	$73.3M	Buy	+164,874	New	+$76.1M	0.75%	47
2020 Q3	–	Sell	-112,500	Closed	-$29.6M	–	47
2020 Q2	$29.6M	Sell	112,500 -137,500	-55%	-$36.7M	0.23%	48
2020 Q1	$56.8M	Buy	250,000 +175,000	+233%	+$47.7M	0.55%	43
2019 Q4	$22.7M	Buy	+75,000	New	+$20.6M	0.18%	51

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Findlay Park Partners's ELV Position: Q1 2025 in Review

Findlay Park Partners sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 369,351 shares — an estimated $136M sold.

Findlay Park Partners first reported a position in ELV in Q4 2019 and held it in 10 quarters. The position peaked at $189M in Q3 2024. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

Findlay Park Partners reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
Findlay Park Partners sold 369,351 Elevance Health shares in Q1 2025, an estimated $136M.
Findlay Park Partners first reported a position in Elevance Health in Q4 2019 and held it in 10 quarters.
Findlay Park Partners's Elevance Health position peaked at $189M in Q3 2024.
1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Findlay Park Partners's 13F filing for Q1 2025, filed 14 May 2025.